195 related articles for article (PubMed ID: 10382935)
1. Clinical use of rHuEPO in bone marrow transplantation.
Klaesson S
Med Oncol; 1999 Apr; 16(1):2-7. PubMed ID: 10382935
[TBL] [Abstract][Full Text] [Related]
2. Use of recombinant human erythropoietin after bone marrow transplantation in pediatric patients with acute leukemia: effect on erythroid repopulation in autologous versus allogeneic transplants.
Locatelli F; Zecca M; Pedrazzoli P; Prete L; Quaglini S; Comoli P; De Stefano P; Beguin Y; Robustelli della Cuna G; Severi F
Bone Marrow Transplant; 1994 Apr; 13(4):403-10. PubMed ID: 8019464
[TBL] [Abstract][Full Text] [Related]
3. A controlled trial of recombinant human erythropoietin after bone marrow transplantation.
Link H; Boogaerts MA; Fauser AA; Slavin S; Reiffers J; Gorin NC; Carella AM; Mandelli F; Burdach S; Ferrant A
Blood; 1994 Nov; 84(10):3327-35. PubMed ID: 7949088
[TBL] [Abstract][Full Text] [Related]
4. Recombinant human erythropoietin for the treatment of the anaemia associated with autologous bone marrow transplantation.
Ayash LJ; Elias A; Hunt M; Demetri G; Wheeler C; Tepler I; Schwartz G; Mazanet R; Reich E; McCauley M
Br J Haematol; 1994 May; 87(1):153-61. PubMed ID: 7947240
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin plus iron versus control treatment including placebo or iron for preoperative anaemic adults undergoing non-cardiac surgery.
Kaufner L; von Heymann C; Henkelmann A; Pace NL; Weibel S; Kranke P; Meerpohl JJ; Gill R
Cochrane Database Syst Rev; 2020 Aug; 8(8):CD012451. PubMed ID: 32790892
[TBL] [Abstract][Full Text] [Related]
6. The use of erythropoietin in the treatment of post-bone marrow transplantation anemia.
Vannucchi AM; Bosi A; Grossi A; Guidi S; Saccardi R; Bacci P; Lombardini L; Rossi-Ferrini P
Int J Artif Organs; 1993 Dec; 16 Suppl 5():8-12. PubMed ID: 8014003
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human erythropoietin is effective in correcting erythropoietin-deficient anaemia after allogeneic bone marrow transplantation.
Locatelli F; Pedrazzoli P; Barosi G; Zecca M; Porta F; Liberato L; Gambarana D; Nespoli L; Cazzola M
Br J Haematol; 1992 Apr; 80(4):545-9. PubMed ID: 1581240
[TBL] [Abstract][Full Text] [Related]
8. Use of recombinant human erythropoietin in allogeneic bone marrow transplant donor/recipient pairs.
Mitus AJ; Antin JH; Rutherford CJ; McGarigle CJ; Goldberg MA
Blood; 1994 Apr; 83(7):1952-7. PubMed ID: 8142661
[TBL] [Abstract][Full Text] [Related]
9. [The role of human recombinant erythropoietin in oncologic surgery].
Mercuriali F
Tumori; 1997; 83(4 Suppl 2):S16-9. PubMed ID: 9487379
[TBL] [Abstract][Full Text] [Related]
10. Anemia and epoetin alfa in high-dose chemotherapy programs for breast cancer patients.
Danova M; Ferrari S
Semin Oncol; 2002 Jun; 29(3 Suppl 8):21-5. PubMed ID: 12082650
[TBL] [Abstract][Full Text] [Related]
11. Reduced blood transfusions requirements after allogeneic bone marrow transplantation: results of a randomised, double-blind study with high-dose erythropoietin.
Klaesson S; Ringdén O; Ljungman P; Lönnqvist B; Wennberg L
Bone Marrow Transplant; 1994 Apr; 13(4):397-402. PubMed ID: 8019463
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin in stem cell transplantation.
Miller CB; Lazarus HM
Bone Marrow Transplant; 2001 May; 27(10):1011-6. PubMed ID: 11438814
[TBL] [Abstract][Full Text] [Related]
13. Combination therapy with G-CSF and erythropoietin after autologous bone marrow transplantation for lymphoid malignancies: a randomized trial.
Vannucchi AM; Bosi A; Ieri A; Guidi S; Saccardi R; Lombardini L; Linari S; Laszlo D; Longo G; Rossi-Ferrini P
Bone Marrow Transplant; 1996 Apr; 17(4):527-31. PubMed ID: 8722349
[TBL] [Abstract][Full Text] [Related]
14. High doses of recombinant human erythropoietin fail to accelerate platelet reconstitution in allogeneic bone marrow transplantation. Results of a pilot study.
Vannucchi AM; Bosi A; Linari S; Guidi S; Longo G; Lombardini L; Mariani MP; Saccardi R; Laszlo D; Rossi Ferrini P
Haematologica; 1997; 82(1):53-6. PubMed ID: 9107083
[TBL] [Abstract][Full Text] [Related]
15. Accelerated erythroid repopulation with no stem-cell competition effect in children treated with recombinant human erythropoietin after allogeneic bone marrow transplantation.
Locatelli F; Zecca M; Beguin Y; Giorgiani G; Ponchio L; De Stefano P; Cazzola M
Br J Haematol; 1993 Aug; 84(4):752-4. PubMed ID: 8217839
[TBL] [Abstract][Full Text] [Related]
16. Administration of recombinant human erythropoietin alpha before autologous stem cell transplantation reduces transfusion requirement in multiple myeloma patients.
Martino M; Oliva E; Console G; Stelitano C; Fujo M; Messina G; Irrera G; Pucci G; Mandaglio R; Callea V; Nobile F; Iacopino P; Morabito F
Support Care Cancer; 2005 Mar; 13(3):182-7. PubMed ID: 15480819
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human erythropoietin therapy is very effective after an autologous peripheral blood stem cell transplant when started soon after engraftment.
Baron F; Frère P; Fillet G; Beguin Y
Clin Cancer Res; 2003 Nov; 9(15):5566-72. PubMed ID: 14654537
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of erythroid marrow response to recombinant human erythropoietin in patients with cancer anaemia.
Ponchio L; Beguin Y; Farina G; Pedrazzoli P; Pedrotti C; Poggi G; Rosti V; Bergamaschi G; Battistel V; Cazzola M
Haematologica; 1992; 77(6):494-501. PubMed ID: 1289186
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of recombinant human erythropoietin for reducing red blood cells transfusions in critically ill patients.
MacLaren R; Sullivan PW
Value Health; 2005; 8(2):105-16. PubMed ID: 15804319
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human erythropoietin for late-onset anemia after allogeneic bone marrow transplantation.
Fujimori Y; Kanamaru A; Saheki K; Mori A; Takatsuka H; Wada H; Okada M; Tamura S; Okamoto T; Takemoto Y; Kakishita E; Nagai K
Int J Hematol; 1998 Feb; 67(2):131-6. PubMed ID: 9631579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
